Clinica Universidad de Navarra, Universidad de Navarra
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent prior to the performance of any procedure related to the clinical trial.
Female, 18 years of age or older at the time of inclusion.
Patients with a histopathological diagnosis of malignant ovarian tumor in a deferred study (any epithelial histology), in apparent early stage FIGO I-II, proposed for staging surgery, or patients with suspected malignant ovarian tumor in apparent early stage FIGO I-II, who will undergo exploratory laparotomy and operative biopsy, and if positive, will undergo staging surgery.
You may not be if
Failure to obtain informed consent or revocation of informed consent.
Under 18 years of age at the time of inclusion.
Previous history of vascular surgery on the aorta, vena cava, or pelvic vessels.
Previous pelvic or paraaortic lymphatic surgery.
Previous lymphoma.
Previous abdomino-pelvic tumor.
Previous allergy to Tc99 or ICG.
Pregnancy/Breastfeeding.
Clareo Health | Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)
